CORC  > 中国医学科学院 北京协和医学院
A novel anti-cancer agent icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Zhao, Hong; Guo, Yuming; Li, Shu; Han, Ruiqin; Ying, Jianming; Zhu, Hai; Wang, Yuanyuan; Yin, Li; Han, Yuqing; Sun, Lingzhi
2015
卷号26期号:31页码:67-67
关键词Icaritin HCC HCC initiating cells IL-6 receptors Stat3
ISSN号0923-7534
DOI10.18632/oncotarget.5578
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6664073
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zhao, Hong,Guo, Yuming,Li, Shu,et al. A novel anti-cancer agent icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway[J],2015,26(31):67-67.
APA Zhao, Hong.,Guo, Yuming.,Li, Shu.,Han, Ruiqin.,Ying, Jianming.,...&Cai, Jianqiang.(2015).A novel anti-cancer agent icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.,26(31),67-67.
MLA Zhao, Hong,et al."A novel anti-cancer agent icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway".26.31(2015):67-67.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace